Keyword Analysis & Research: insulin glargine drug study

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
insulin glargine drug study	0.61	0.1	202	88	27
insulin	1.45	0.6	9283	46	7
glargine	0.42	0.4	4876	29	8
drug	0.12	0.3	2540	43	4
study	1.19	0.8	8387	54	5

Keyword	CPC	PCC	Volume	Score
insulin glargine drug study	1.13	0.6	654	53
insulin glargine drug study scribd	1.57	0.4	1221	24
insulin glargine drug class	0.36	0.8	1077	2
glargine and regular insulin	0.23	0.4	890	84
insulin glargine therapeutic use	0.91	1	1460	49
glargine long acting insulin	0.07	0.7	7925	9
insulin glargine therapeutic effect	1.33	0.4	9225	37
pharmacokinetics of insulin glargine	0.4	1	8091	95
insulin glargine classification of drug	0.16	0.4	3333	52
insulin glargine pharmacological class	1.93	0.7	1982	98
insulin glargine therapeutic class	0.01	0.2	8736	83
what is glargine insulin	0.68	0.1	9980	49
glargine type of insulin	0.47	0.9	8117	18
is insulin glargine rapid acting	0.88	0.7	1175	35
pharm class of insulin glargine	0.91	0.1	9660	4
pharmacodynamics of insulin glargine	0.02	1	6117	33
insulin glargine used for	0.41	1	9140	8

Insulin glargine Uses, Side Effects & Warnings - Drugs.com
drugs.com

https://www.drugs.com/mtm/insulin-glargine.html

DA: 45 PA: 18 MOZ Rank: 54

Insulin glargine Uses, Side Effects & Warnings - Drugs.com
drugs.com

https://www.drugs.com/mtm/insulin-glargine.html

WebFeb 18, 2022 · Insulin glargine is a long-acting insulin that starts to work several hours after injection and keeps working evenly for 24 hours. Insulin glargine is used to improve blood sugar control in people with diabetes mellitus. Toujeo is for use in adults with type … drug study

drug study

DA: 38 PA: 5 MOZ Rank: 51

Glargine Insulin - StatPearls - NCBI Bookshelf
nih.gov

https://www.ncbi.nlm.nih.gov/books/NBK557756/

WebApr 21, 2022 · Insulin glargine is a synthetic version of human insulin that is FDA approved to treat adults and children with type 1 diabetes and … Authors: Abigail M. Cunningham, Andrew M. Freeman Published: 2022/04/21

Authors: Abigail M. Cunningham, Andrew M. Freeman
Published: 2022/04/21

DA: 74 PA: 16 MOZ Rank: 85

Lantus Insulin: Side Effects, Dosage, Uses, and More
healthline.com

https://www.healthline.com/health/drugs/lantus

WebJan 12, 2023 · Lantus contains the active drug insulin glargine, which is a biologic …

DA: 43 PA: 33 MOZ Rank: 41

Insulin glargine: Uses, Interactions, Mechanism of Action
drugbank.com

https://go.drugbank.com/drugs/DB00047

Web504 rows · Insulin glargine is a long-acting insulin analogue with a flat …

DA: 65 PA: 84 MOZ Rank: 14

FDA Approves First Interchangeable Biosimilar Insulin …
fda.gov

https://www.fda.gov/news-events/press-announcements/fda-approves-first-interchangeable-biosimilar-insulin-product-treatment-diabetes

WebSemglee (insulin glargine-yfgn) is the first interchangeable biosimilar product approved …

DA: 24 PA: 30 MOZ Rank: 63

Two popular diabetes drugs outperformed others in large …
nih.gov

https://www.nih.gov/news-events/news-releases/two-popular-diabetes-drugs-outperformed-others-large-clinical-trial

WebSep 21, 2022 · In a large clinical trial that directly compared four drugs commonly used …

DA: 18 PA: 36 MOZ Rank: 26

Initiation of insulin glargine therapy in type 2 diabetes …
nih.gov

https://pubmed.ncbi.nlm.nih.gov/18355327/

WebThe AT.LANTUS study investigated optimal methods to initiate and maintain insulin …

DA: 11 PA: 68 MOZ Rank: 45

Insulin Glargine/Lixisenatide: A Review in Type 2 Diabetes
nih.gov

https://pubmed.ncbi.nlm.nih.gov/28667587/

WebSubcutaneous insulin glargine/lixisenatide (Suliqua™) is a titratable, fixed-ratio …

DA: 1 PA: 77 MOZ Rank: 56

DailyMed - INSULIN GLARGINE U-300- insulin glargine …
nih.gov

https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=99ea856d-9562-443a-9422-1006a3cff2f4

WebIn an open-label, controlled study (Study A), patients with type 1 diabetes (n=546), were …

DA: 17 PA: 75 MOZ Rank: 81

To Compare the Efficacy and Safety of INS068 and Insulin …
clinicaltrials.gov

https://clinicaltrials.gov/ct2/show/NCT05699408

WebJan 26, 2023 · Study Description Go to Brief Summary: The study is being conducted to …

DA: 97 PA: 5 MOZ Rank: 20